Efficacy and Safety of Widely Used Treatments for Macular Oedema Secondary to Retinal Vein Occlusion
In conclusion, data from high-quality RCTs for ranibizumab and dexamethasone IVT have demonstrated that both new agents have promising outcomes for the treatment of BRVO and CRVO, and constitute ...
STOCKHOLM — A real-world analysis of retrospective data showed that administering more anti-VEGF injections over a 5-year time span to treat macular edema secondary to retinal vein occlusion (RVO) was ...
Overview of study design and analytical flow for identifying metabolic features associated with anti-VEGF therapy on macular edema (ME) patients (created with BioRender.com). anti-VEGF, anti-vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results